XML 15 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
ASSETS    
Cash and cash equivalents $ 251,022 $ 20,931
Restricted cash 27,919 0
Trade and other receivables, net 26,867 71,250
Accounts receivable from related parties 2,933 5,401
Inventories 14,239 16,649
Prepayments and other assets 45,963 44,691
Property and equipment, net 1,805,242 1,929,914
Goodwill, net 62,166 78,339
Other intangible assets 8,555 8,408
Deferred tax assets 22,358 21,381
Total assets 2,267,264 2,196,964
LIABILITIES AND SHAREHOLDERS' EQUITY    
Trade and other payables 121,238 181,603
Payables to related parties 9,260 7,620
Income tax payable 1,813 3,252
Debt 1,251,877 1,040,658
Derivative financial instruments 55,477 31,932
Other liabilities 30,696 24,307
Deferred tax liabilities 86,345 97,941
Total liabilities 1,556,706 1,387,313
Commitments and contingencies (see Note 7)
Shareholders' equity    
Ordinary shares (par value €0.10; 500,000,000 shares authorized, 136,684,273 shares issued and 134,485,477 shares outstanding as of June 30, 2020, and 130,967,671 shares issued and 129,121,576 shares outstanding as of December 31, 2019) 14,861 14,215
Treasury shares (at cost, 2,198,796 shares as of June 30, 2020 and 1,846,095 shares as of December 31, 2019) (16,642) (14,088)
Paid-in capital 1,025,942 1,001,088
Accumulated other comprehensive loss (36,667) (24,642)
Accumulated deficit (276,936) (166,922)
Total shareholders' equity 710,558 809,651
Total liabilities and shareholders' equity $ 2,267,264 $ 2,196,964